| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP13A4 MYH13 MYO10 DDX60 BTAF1 KIF20B MDN1 FBH1 KCNJ8 DNAH17 ABCD3 ATP2B1 HSPA9 DYNC1H1 ACSL5 | 5.72e-06 | 614 | 123 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | 8.27e-05 | 227 | 123 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 2.34e-04 | 49 | 123 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ECM2 OBSCN NFASC ACTN3 FMNL2 SH3GLB1 TJP1 TLN2 CTNNA2 SCRIB CDH6 VCL | 3.31e-04 | 599 | 123 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP13A4 DDX60 BTAF1 KIF20B MDN1 FBH1 ABCD3 ATP2B1 HSPA9 DYNC1H1 | 4.06e-04 | 441 | 123 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | calmodulin binding | 5.63e-04 | 230 | 123 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP13A4 DDX60 BTAF1 KIF20B RIT1 MDN1 FBH1 GBP5 ASMTL ABCD3 ATP2B1 TUBB8B HSPA9 DYNC1H1 | 6.63e-04 | 839 | 123 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP13A4 DDX60 BTAF1 KIF20B RIT1 MDN1 FBH1 GBP5 ASMTL ABCD3 ATP2B1 TUBB8B HSPA9 DYNC1H1 | 6.71e-04 | 840 | 123 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP13A4 DDX60 BTAF1 KIF20B RIT1 MDN1 FBH1 GBP5 ASMTL ABCD3 ATP2B1 TUBB8B HSPA9 DYNC1H1 | 6.71e-04 | 840 | 123 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 8.21e-04 | 118 | 123 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 8.86e-04 | 120 | 123 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP13A4 DDX60 BTAF1 KIF20B RIT1 MDN1 FBH1 GBP5 ABCD3 ATP2B1 TUBB8B HSPA9 DYNC1H1 | 9.90e-04 | 775 | 123 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | cadherin binding | 1.21e-03 | 339 | 123 | 8 | GO:0045296 | |
| GeneOntologyBiologicalProcess | protein localization to adherens junction | 4.09e-06 | 6 | 123 | 3 | GO:0071896 | |
| GeneOntologyBiologicalProcess | organelle assembly | TPR DCAF13 RPS6 OBSCN OBSL1 SNAP29 DNAJB13 MDN1 SH3GLB1 ALMS1 FAM161A PRRC2C DNAH17 AKT1 CEP295 PRKDC ACTL9 PIBF1 DYNC1H1 KNL1 | 1.28e-05 | 1138 | 123 | 20 | GO:0070925 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | TPR DCAF13 RPS6 OBSCN OBSL1 MDN1 ALMS1 PRRC2C CEP295 PRKDC PIBF1 DYNC1H1 | 2.76e-05 | 475 | 123 | 12 | GO:0140694 |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.87e-05 | 94 | 122 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | intercalated disc | 4.85e-05 | 68 | 122 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | myofibril | 2.04e-04 | 273 | 122 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.06e-04 | 290 | 122 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | microtubule associated complex | 3.68e-04 | 161 | 122 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | centrosome | DCAF13 RANBP9 OBSL1 KIF20B CCNB1 SNAP29 ALMS1 FAM161A AK5 PDE4DIP CEP295 PIBF1 DYNC1H1 | 5.68e-04 | 770 | 122 | 13 | GO:0005813 |
| Domain | Vinculin/catenin | 8.66e-06 | 7 | 119 | 3 | IPR006077 | |
| Domain | ALMS_motif | 1.20e-04 | 3 | 119 | 2 | IPR029299 | |
| Domain | ALMS_motif | 1.20e-04 | 3 | 119 | 2 | PF15309 | |
| Domain | VINCULIN_1 | 2.40e-04 | 4 | 119 | 2 | PS00663 | |
| Domain | Vinculin_CS | 2.40e-04 | 4 | 119 | 2 | IPR000633 | |
| Domain | P-loop_NTPase | MYH13 MYO10 DDX60 BTAF1 KIF20B RIT1 SAMD9L NWD2 MDN1 FBH1 GBP5 TJP1 AK5 ABCD3 DYNC1H1 | 3.21e-04 | 848 | 119 | 15 | IPR027417 |
| Domain | Vinculin | 3.98e-04 | 5 | 119 | 2 | PF01044 | |
| Domain | TPR-contain_dom | 4.00e-04 | 150 | 119 | 6 | IPR013026 | |
| Domain | TPR-like_helical_dom | 7.37e-04 | 233 | 119 | 7 | IPR011990 | |
| Domain | IQ | 1.10e-03 | 71 | 119 | 4 | PF00612 | |
| Domain | Drf_GBD | 1.41e-03 | 9 | 119 | 2 | PF06371 | |
| Domain | Drf_FH3 | 1.41e-03 | 9 | 119 | 2 | PF06367 | |
| Domain | ZU5 | 1.41e-03 | 9 | 119 | 2 | SM00218 | |
| Domain | FH3_dom | 1.41e-03 | 9 | 119 | 2 | IPR010472 | |
| Domain | GTPase-bd | 1.41e-03 | 9 | 119 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 1.41e-03 | 9 | 119 | 2 | SM01139 | |
| Domain | Drf_GBD | 1.41e-03 | 9 | 119 | 2 | SM01140 | |
| Domain | HMG_BOX_1 | 1.75e-03 | 10 | 119 | 2 | PS00353 | |
| Domain | ZU5 | 1.75e-03 | 10 | 119 | 2 | PS51145 | |
| Domain | IQ | 1.79e-03 | 81 | 119 | 4 | SM00015 | |
| Domain | - | 2.12e-03 | 207 | 119 | 6 | 1.25.40.10 | |
| Domain | GBD/FH3_dom | 2.13e-03 | 11 | 119 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 2.13e-03 | 11 | 119 | 2 | PS51232 | |
| Domain | ZU5 | 2.55e-03 | 12 | 119 | 2 | PF00791 | |
| Domain | ZU5_dom | 2.55e-03 | 12 | 119 | 2 | IPR000906 | |
| Domain | IQ_motif_EF-hand-BS | 2.63e-03 | 90 | 119 | 4 | IPR000048 | |
| Domain | - | DDX60 BTAF1 RIT1 SAMD9L NWD2 MDN1 FBH1 GBP5 TJP1 AK5 ABCD3 DYNC1H1 | 2.88e-03 | 746 | 119 | 12 | 3.40.50.300 |
| Domain | IQ | 2.96e-03 | 93 | 119 | 4 | PS50096 | |
| Domain | ATPase_dyneun-rel_AAA | 3.48e-03 | 14 | 119 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.48e-03 | 14 | 119 | 2 | PF07728 | |
| Domain | FH2 | 4.00e-03 | 15 | 119 | 2 | PS51444 | |
| Domain | FH2_Formin | 4.00e-03 | 15 | 119 | 2 | IPR015425 | |
| Domain | FH2 | 4.00e-03 | 15 | 119 | 2 | PF02181 | |
| Domain | FH2 | 4.00e-03 | 15 | 119 | 2 | SM00498 | |
| Domain | TPR_REGION | 4.12e-03 | 165 | 119 | 5 | PS50293 | |
| Domain | TPR | 4.12e-03 | 165 | 119 | 5 | PS50005 | |
| Domain | AGC-kinase_C | 5.47e-03 | 56 | 119 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 5.47e-03 | 56 | 119 | 3 | PS51285 | |
| Domain | S_TK_X | 5.47e-03 | 56 | 119 | 3 | SM00133 | |
| Domain | Cation_ATPase_N | 5.76e-03 | 18 | 119 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 5.76e-03 | 18 | 119 | 2 | SM00831 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 2.20e-05 | 9 | 92 | 3 | MM1366 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 3.17e-05 | 93 | 92 | 6 | M42521 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 5.67e-05 | 12 | 92 | 3 | M12851 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SECISBP2L ATP5ME DNAJC13 AMER1 VPS45 UBE3B RANBP9 OBSL1 SRP68 KLC4 FMNL2 SNAP29 SH3GLB1 ABCD3 PRPF38A PIBF1 VPS51 DYNC1H1 VCL CCDC93 | 5.45e-08 | 1321 | 125 | 20 | 27173435 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR DNAJC13 DCAF13 RPS6 RANBP9 SLU7 SRP68 PFAS KIF20B CRNKL1 MDN1 ABCD3 PRPF38A PRKDC SCRIB ATP2B1 HSPA9 DYNC1H1 VCL CCDC93 | 8.03e-08 | 1353 | 125 | 20 | 29467282 |
| Pubmed | TPR DCAF13 RPS6 SRP68 PFAS CRNKL1 MDN1 TJP1 PRRC2C NUP210 PRKDC HSPA9 DYNC1H1 VCL | 1.06e-07 | 653 | 125 | 14 | 22586326 | |
| Pubmed | DNAJC13 AMER1 MYH13 VPS45 RPS6 SRP68 FMNL2 PKHD1L1 SNAP29 TJP1 ABCD3 PRKDC SCRIB HSPA9 DYNC1H1 | 1.41e-07 | 777 | 125 | 15 | 35844135 | |
| Pubmed | 1.55e-07 | 14 | 125 | 4 | 19652092 | ||
| Pubmed | VPS45 RANBP9 NAP1L2 OBSL1 BRCC3 FMNL2 DMAP1 NUFIP1 TRIM66 CRNKL1 FBH1 TJP1 PDE4DIP RNF216 TLN2 PRKDC SCRIB HSPA9 DYNC1H1 | 1.75e-07 | 1285 | 125 | 19 | 35914814 | |
| Pubmed | DNAJC13 VPS45 RPS6 SRP68 NFASC ACTN3 FMNL2 NWD2 TJP1 PRRC2C PDE4DIP ABCD3 TLN2 CTNNA2 SCRIB VPS51 ATP2B1 HSPA9 DYNC1H1 VCL | 1.97e-07 | 1431 | 125 | 20 | 37142655 | |
| Pubmed | TPR UNC5B RPS6 SRP68 SNAP29 PRRC2C ABCD3 PRKDC SCRIB ATP2B1 EIF2AK3 HSPA9 DYNC1H1 VCL | 2.83e-07 | 708 | 125 | 14 | 39231216 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.01e-07 | 256 | 125 | 9 | 33397691 | |
| Pubmed | 7.41e-07 | 202 | 125 | 8 | 24639526 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR DNAJC13 SRP68 BTAF1 CCNB1 MDN1 TLN2 PRKDC SCRIB VPS51 DYNC1H1 KNL1 | 1.36e-06 | 582 | 125 | 12 | 20467437 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR RPS6 SRP68 PFAS BTAF1 SNAP29 ALMS1 TJP1 PRRC2C ABCD3 PRKDC SCRIB HSPA9 VCL KNL1 | 1.42e-06 | 934 | 125 | 15 | 33916271 |
| Pubmed | DNAJC13 DCAF13 UNC5B OBSL1 SLU7 PFAS TIMMDC1 DNAJB13 MDN1 TMTC3 NUP210 ABCD3 ADI1 SCRIB PIBF1 ATP2B1 EIF2AK3 HSPA9 VCL | 1.57e-06 | 1487 | 125 | 19 | 33957083 | |
| Pubmed | SECISBP2L PFAS FMNL2 TRIM66 RIMKLB SAMD9L CMIP SH3GLB1 ALMS1 DNAH17 NUP210 | 1.80e-06 | 493 | 125 | 11 | 15368895 | |
| Pubmed | 2.17e-06 | 104 | 125 | 6 | 9205841 | ||
| Pubmed | FAT3 RANBP9 OBSL1 ZKSCAN2 FMNL2 DMAP1 HMG20B NUFIP1 SNAP29 TRIM66 TCHH ALMS1 CEP295 SCRIB VPS51 KNL1 | 2.67e-06 | 1116 | 125 | 16 | 31753913 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR SATB2 OBSL1 SLU7 BTAF1 DMAP1 HMG20B MDN1 PRRC2C ASMTL SCRIB ATP2B1 EIF2AK3 DYNC1H1 | 2.68e-06 | 857 | 125 | 14 | 25609649 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPR MYH13 ACTN3 MDN1 PRRC2C NUP210 PRKDC SCRIB ATP2B1 HSPA9 DYNC1H1 VCL | 4.04e-06 | 647 | 125 | 12 | 26618866 |
| Pubmed | TPR SRP68 DMAP1 SNAP29 ALMS1 TJP1 PRRC2C PRKDC SCRIB DYNC1H1 VCL | 5.03e-06 | 549 | 125 | 11 | 38280479 | |
| Pubmed | 5.89e-06 | 267 | 125 | 8 | 33417871 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 6.73e-06 | 361 | 125 | 9 | 26167880 | |
| Pubmed | 6.74e-06 | 272 | 125 | 8 | 31010829 | ||
| Pubmed | 7.32e-06 | 11 | 125 | 3 | 24095903 | ||
| Pubmed | TPR AMER1 RCCD1 RPS6 RANBP9 SRP68 KIF20B CCNB1 MDN1 ABCD3 PRKDC HSPA9 DYNC1H1 | 7.42e-06 | 809 | 125 | 13 | 32129710 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 8.98e-06 | 202 | 125 | 7 | 33005030 | |
| Pubmed | Chromatin Remodeling BAF155 Subunit Regulates the Genesis of Basal Progenitors in Developing Cortex. | 1.07e-05 | 38 | 125 | 4 | 30240734 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPR DCAF13 DDX60 RPS6 SLU7 SRP68 KIF20B CRNKL1 TJP1 PRRC2C NUP210 ABCD3 PRKDC SCRIB HSPA9 DYNC1H1 | 1.19e-05 | 1257 | 125 | 16 | 36526897 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPR MYH13 RPS6 CARS1 BRCC3 MDN1 PRRC2C TLN2 PRKDC ATP2B1 HSPA9 DYNC1H1 CCDC93 | 1.21e-05 | 847 | 125 | 13 | 35235311 |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18439899 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29104511 | ||
| Pubmed | Integrin-mediated cell adhesion: the cytoskeletal connection. | 1.28e-05 | 2 | 125 | 2 | 10320934 | |
| Pubmed | Phosphoinositides regulate force-independent interactions between talin, vinculin, and actin. | 1.28e-05 | 2 | 125 | 2 | 32657269 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32859055 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28377452 | ||
| Pubmed | DNA damage promotes microtubule dynamics through a DNA-PK-AKT axis for enhanced repair. | 1.28e-05 | 2 | 125 | 2 | 33404607 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31751425 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19144640 | ||
| Pubmed | Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway. | 1.28e-05 | 2 | 125 | 2 | 17311300 | |
| Pubmed | Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. | 1.28e-05 | 2 | 125 | 2 | 15262962 | |
| Pubmed | DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance. | 1.28e-05 | 2 | 125 | 2 | 22131882 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 33624744 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28327544 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22790947 | ||
| Pubmed | Akt phosphorylation in human chondrocytes is regulated by p53R2 in response to mechanical stress. | 1.28e-05 | 2 | 125 | 2 | 22954457 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 35471687 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18644989 | ||
| Pubmed | ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits. | 1.28e-05 | 2 | 125 | 2 | 30421101 | |
| Pubmed | RPS6 OBSCN SRP68 ACTN3 CCNB1 SH3GLB1 ALMS1 PDE4DIP HSPA9 VCL | 1.33e-05 | 497 | 125 | 10 | 23414517 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | OBSCN SRP68 NFASC FMNL2 OTUB2 SAMD9L MDN1 ABCD3 CEP295 PRKDC SCRIB DYNC1H1 | 1.47e-05 | 736 | 125 | 12 | 29676528 |
| Pubmed | 1.54e-05 | 146 | 125 | 6 | 21399614 | ||
| Pubmed | ATP5ME VPS45 DDX60 RANBP9 BTAF1 CCNB1 SNAP29 MDN1 PRRC2C NUP210 ABCD3 PRKDC CTNNA2 SCRIB ATP2B1 DYNC1H1 CCDC93 | 1.64e-05 | 1440 | 125 | 17 | 30833792 | |
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 1.86e-05 | 226 | 125 | 7 | 25900982 | |
| Pubmed | TPR DCAF13 DDX60 CARS1 SRP68 BRCC3 CCNB1 SERPINB9 MDN1 AKT1 CTNNA2 | 1.92e-05 | 634 | 125 | 11 | 34591612 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR RPS6 OBSL1 BTAF1 CRNKL1 MDN1 TJP1 NUP210 ABCD3 PRKDC SCRIB ATP2B1 HSPA9 DYNC1H1 | 1.99e-05 | 1024 | 125 | 14 | 24711643 |
| Pubmed | 2.00e-05 | 15 | 125 | 3 | 17400507 | ||
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 2.28e-05 | 322 | 125 | 8 | 39098523 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SECISBP2L AMER1 MYO10 RPS6 SLU7 SRP68 HMG20B CCNB1 NUFIP1 SNAP29 RIMKLB TJP1 RNF216 PRPF38A | 2.31e-05 | 1038 | 125 | 14 | 26673895 |
| Pubmed | 2.32e-05 | 234 | 125 | 7 | 36243803 | ||
| Pubmed | 3.56e-05 | 18 | 125 | 3 | 33462112 | ||
| Pubmed | Scrib:Rac1 interactions are required for the morphogenesis of the ventricular myocardium. | 3.56e-05 | 18 | 125 | 3 | 25139745 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 29563586 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 38842166 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 25264192 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 38760896 | ||
| Pubmed | Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex. | 3.84e-05 | 3 | 125 | 2 | 20133654 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 23589308 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 30645777 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 19781633 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 23135917 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 27989621 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 18757368 | ||
| Pubmed | Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt. | 3.84e-05 | 3 | 125 | 2 | 21701506 | |
| Pubmed | Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico. | 3.84e-05 | 3 | 125 | 2 | 12684686 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 18579686 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 37643197 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 34948148 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 19952892 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 31098411 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 12646231 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 16785234 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 20844083 | ||
| Pubmed | Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study. | 3.84e-05 | 3 | 125 | 2 | 27816808 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 24574517 | ||
| Pubmed | Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. | 3.84e-05 | 3 | 125 | 2 | 15494027 | |
| Pubmed | Vinculin controls talin engagement with the actomyosin machinery. | 3.84e-05 | 3 | 125 | 2 | 26634421 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 24413171 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 32961022 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 21532145 | ||
| Pubmed | Molecular basis of the head-to-tail assembly of giant muscle proteins obscurin-like 1 and titin. | 3.84e-05 | 3 | 125 | 2 | 20489725 | |
| Pubmed | FMNL2 and -3 regulate Golgi architecture and anterograde transport downstream of Cdc42. | 3.84e-05 | 3 | 125 | 2 | 28852060 | |
| Pubmed | 4.20e-05 | 106 | 125 | 5 | 19394292 | ||
| Pubmed | TPR DNAJC13 RANBP9 NFASC MDN1 TJP1 PRRC2C PDE4DIP TLN2 CTNNA2 SCRIB HSPA9 DYNC1H1 | 4.56e-05 | 963 | 125 | 13 | 28671696 | |
| Pubmed | TPR ATP5ME RPS6 SNAP29 MDN1 NUP210 PRKDC SCRIB HSPA9 DYNC1H1 VCL | 5.17e-05 | 707 | 125 | 11 | 19738201 | |
| Pubmed | 5.25e-05 | 469 | 125 | 9 | 27634302 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR DCAF13 RPS6 CARS1 SRP68 PFAS CRNKL1 MDN1 NUP210 ABCD3 TLN2 PRKDC ATP2B1 HSPA9 DYNC1H1 VCL | 5.39e-05 | 1425 | 125 | 16 | 30948266 |
| Pubmed | Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis. | 5.75e-05 | 21 | 125 | 3 | 23637172 | |
| Pubmed | E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. | 5.75e-05 | 21 | 125 | 3 | 15775979 | |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 5.88e-05 | 271 | 125 | 7 | 25737280 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 5.98e-05 | 477 | 125 | 9 | 31300519 | |
| Pubmed | ATP5ME DCAF13 AMER1 MYH13 RPS6 ACTN3 CCDC148 RIMKLB MDN1 TJP1 FAM161A PRRC2C CEP295 PRKDC ATP2B1 HSPA9 | 6.20e-05 | 1442 | 125 | 16 | 35575683 | |
| Interaction | BRCA1 interactions | TPR ZBTB48 RPS6 OBSCN RANBP9 CARS1 SRP68 BRCC3 ACTN3 KIF20B CCNB1 NUFIP1 RIT1 SERPINB9 MDN1 ALMS1 FAM161A RNF216 AKT1 C2CD6 PRKDC HSPA9 DYNC1H1 VCL KNL1 | 9.93e-08 | 1249 | 122 | 25 | int:BRCA1 |
| Interaction | PHLPP1 interactions | TPR ATP5ME RPS6 SRP68 TJP1 PRRC2C AKT1 PRKDC SCRIB DYNC1H1 KNL1 | 5.83e-06 | 333 | 122 | 11 | int:PHLPP1 |
| Interaction | ITGB3 interactions | 9.25e-06 | 170 | 122 | 8 | int:ITGB3 | |
| Interaction | RPS6KL1 interactions | 1.41e-05 | 51 | 122 | 5 | int:RPS6KL1 | |
| Interaction | CDC5L interactions | TPR RPS6 OBSL1 SRP68 BTAF1 CCDC12 CCNB1 RIT1 CRNKL1 MDN1 PDE4DIP TLN2 PRKDC SCRIB VPS51 DYNC1H1 KNL1 | 1.56e-05 | 855 | 122 | 17 | int:CDC5L |
| Interaction | IGHD interactions | 2.34e-05 | 28 | 122 | 4 | int:IGHD | |
| Interaction | LGR4 interactions | 3.14e-05 | 262 | 122 | 9 | int:LGR4 | |
| Interaction | ECM2 interactions | 3.63e-05 | 2 | 122 | 2 | int:ECM2 | |
| Interaction | SIRT7 interactions | TPR DCAF13 RPS6 SRP68 PFAS CCNB1 CRNKL1 MDN1 TJP1 PRRC2C NUP210 PRKDC HSPA9 DYNC1H1 VCL | 4.40e-05 | 744 | 122 | 15 | int:SIRT7 |
| Interaction | PHF21A interactions | TPR DNAJC13 MYH13 KIF20B HMG20B ALMS1 ABCD3 VPS51 CCDC93 KNL1 | 4.57e-05 | 343 | 122 | 10 | int:PHF21A |
| Interaction | SKI interactions | 5.44e-05 | 160 | 122 | 7 | int:SKI | |
| Interaction | NDEL1 interactions | 6.36e-05 | 164 | 122 | 7 | int:NDEL1 | |
| Interaction | MLF1 interactions | 6.48e-05 | 113 | 122 | 6 | int:MLF1 | |
| Interaction | LZTS2 interactions | TPR SLU7 CCDC12 TRIM66 CRNKL1 OTUB2 ALMS1 TJP1 TTC31 FAM161A CEP295 C2CD6 | 6.56e-05 | 512 | 122 | 12 | int:LZTS2 |
| Interaction | GAPDH interactions | RPS6 OBSCN OBSL1 CCNB1 RIT1 OTUB2 SAMD9L SERPINB9 SH3GLB1 PRRC2C TLN2 AKT1 HSPA9 KNL1 | 7.07e-05 | 686 | 122 | 14 | int:GAPDH |
| Interaction | SDHAF2 interactions | 8.05e-05 | 38 | 122 | 4 | int:SDHAF2 | |
| Interaction | USP7 interactions | TPR AMER1 MYH13 MYO10 DDX60 RPS6 FAT3 RANBP9 NAP1L2 SRP68 BCHE ARHGAP30 BRCC3 RIT1 DNAJB13 SAMD9L MDN1 SH3GLB1 HSPA9 DYNC1H1 | 1.17e-04 | 1313 | 122 | 20 | int:USP7 |
| Interaction | CTNNB1 interactions | FLT1 AMER1 RPS6 OBSL1 BRCC3 FMNL2 OTUB2 TJP1 ABCD3 AKT1 PRKDC CTNNA2 SCRIB CDH6 HSPA9 DYNC1H1 VCL | 1.23e-04 | 1009 | 122 | 17 | int:CTNNB1 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.17e-04 | 161 | 74 | 5 | 593 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.27e-03 | 115 | 74 | 4 | 769 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SECISBP2L DNAJC13 DCAF13 VPS45 CARS1 OBSL1 BTAF1 HMG20B RIT1 MDN1 SH3GLB1 ASMTL NUP210 PDE4DIP PRKDC ADI1 DYNC1H1 VCL CCDC93 | 4.97e-06 | 1215 | 125 | 19 | M41122 |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 6.34e-06 | 145 | 125 | 7 | M3045 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.90e-08 | 194 | 125 | 8 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-07 | 184 | 125 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-07 | 184 | 125 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-07 | 184 | 125 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.54e-06 | 162 | 125 | 6 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.54e-06 | 162 | 125 | 6 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 178 | 125 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 186 | 125 | 6 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 186 | 125 | 6 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.53e-05 | 188 | 125 | 6 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-05 | 192 | 125 | 6 | efbd52b3d2b6d3fb9ed6bc3f36aca9f4f1fcbc49 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.77e-05 | 193 | 125 | 6 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 194 | 125 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.82e-05 | 194 | 125 | 6 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-05 | 194 | 125 | 6 | 3b9ada901dfe7a5cc4861a883d3268c53b11e5b6 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-05 | 196 | 125 | 6 | 92c5be6e43571730c7709046856f6c8ae341a4a1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-05 | 196 | 125 | 6 | 0e7ea6e66bfbb0006ee9651714fe48b0ee194290 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.04e-05 | 198 | 125 | 6 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.16e-05 | 200 | 125 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 145 | 125 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-05 | 148 | 125 | 5 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-05 | 148 | 125 | 5 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-05 | 148 | 125 | 5 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-05 | 157 | 125 | 5 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 158 | 125 | 5 | ee8ce3cd202807df692b28bb1a81827d49d73862 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.15e-05 | 161 | 125 | 5 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.42e-05 | 162 | 125 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.98e-05 | 164 | 125 | 5 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-04 | 165 | 125 | 5 | b1bbf5acdfc52bd8c7c7eb356d73b812eb6b908c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-04 | 165 | 125 | 5 | 28f8297ec7b781149cc7ac2f5e441771083b8ee3 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.06e-04 | 166 | 125 | 5 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-04 | 169 | 125 | 5 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | bca5322880c09b78ef10d9dda6420a80c1ba7e62 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 172 | 125 | 5 | 29c8510f26527d487d0fc3543102d067cdb281a6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 173 | 125 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 174 | 125 | 5 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 174 | 125 | 5 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 175 | 125 | 5 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-04 | 175 | 125 | 5 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.39e-04 | 176 | 125 | 5 | 2a15437c5f5dbf6398d5ea70050632c24a7dc66c | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 177 | 125 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 177 | 125 | 5 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-04 | 178 | 125 | 5 | b169aa5eaa51730daaec69c6bc58126be1592a50 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-04 | 178 | 125 | 5 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 179 | 125 | 5 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.50e-04 | 179 | 125 | 5 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 180 | 125 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 180 | 125 | 5 | 3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 180 | 125 | 5 | 47e345359064dc8ceec982b062e47802e728b43f | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 180 | 125 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 182 | 125 | 5 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 182 | 125 | 5 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 183 | 125 | 5 | b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-04 | 183 | 125 | 5 | 01ad18f198195ce341bae01a1c8c253cc4607766 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 183 | 125 | 5 | 19e7be1cfdd111bfb840532a6f7c780345dffccf | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 1.67e-04 | 183 | 125 | 5 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.71e-04 | 184 | 125 | 5 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | PCW_13-14-Neuronal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.71e-04 | 184 | 125 | 5 | 65cf3460125e3dbc34978957bc138a449f71f7df | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 185 | 125 | 5 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 185 | 125 | 5 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 185 | 125 | 5 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-04 | 185 | 125 | 5 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 1.80e-04 | 186 | 125 | 5 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.80e-04 | 186 | 125 | 5 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.84e-04 | 187 | 125 | 5 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 187 | 125 | 5 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 187 | 125 | 5 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.84e-04 | 187 | 125 | 5 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.89e-04 | 188 | 125 | 5 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass | 1.89e-04 | 188 | 125 | 5 | fd70fb89570f014d1299c60fe017dc09f24e57c6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 188 | 125 | 5 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.89e-04 | 188 | 125 | 5 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-04 | 190 | 125 | 5 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.98e-04 | 190 | 125 | 5 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.98e-04 | 190 | 125 | 5 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-04 | 190 | 125 | 5 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 191 | 125 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-04 | 191 | 125 | 5 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-04 | 191 | 125 | 5 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 191 | 125 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 191 | 125 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG-26|World / Primary Cells by Cluster | 2.08e-04 | 192 | 125 | 5 | b8cf9c3c6b954e93f7504d214e39662bfa8f96f5 | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 2.08e-04 | 192 | 125 | 5 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.13e-04 | 193 | 125 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.13e-04 | 193 | 125 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.18e-04 | 194 | 125 | 5 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-04 | 194 | 125 | 5 | 811b382ec3da06a6bda7360abc8b633f96b2019e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 194 | 125 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-04 | 194 | 125 | 5 | 292ce9021678534c9eedb367b9772a9d976208a8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-04 | 194 | 125 | 5 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-04 | 195 | 125 | 5 | bbafea2262074beede78e286276a1927ecb80582 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-04 | 195 | 125 | 5 | 145c50fa60d9df162152be0a6c070213ebdb8119 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.24e-04 | 195 | 125 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-04 | 196 | 125 | 5 | 624f700daea48d9bad4cc554f4776bd809ae1e54 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-04 | 196 | 125 | 5 | 96e5c6d155273e82ebafa180df8bb589c3e3e54e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-04 | 196 | 125 | 5 | c390ef0adff35111989a30dff86b7c5db1a89873 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-04 | 196 | 125 | 5 | 2f76f050083483f0880639e6c34ff349caac3503 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-04 | 196 | 125 | 5 | ce13af36fc2932e8125013041742593ff3d07e86 | |
| Disease | Parkinson's disease (is_implicated_in) | 1.56e-05 | 76 | 121 | 5 | DOID:14330 (is_implicated_in) | |
| Disease | Pachygyria | 1.65e-04 | 5 | 121 | 2 | C0266483 | |
| Disease | Agyria | 1.65e-04 | 5 | 121 | 2 | C1879312 | |
| Disease | Lissencephaly | 2.47e-04 | 6 | 121 | 2 | C0266463 | |
| Disease | Squamous cell carcinoma of lung | 3.06e-04 | 32 | 121 | 3 | C0149782 | |
| Disease | Drug-induced agranulocytosis, response to clozapine | 6.87e-04 | 42 | 121 | 3 | GO_0097338, HP_0012235 | |
| Disease | bronchopulmonary dysplasia (is_implicated_in) | 1.26e-03 | 13 | 121 | 2 | DOID:11650 (is_implicated_in) | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 1.26e-03 | 13 | 121 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 1.26e-03 | 13 | 121 | 2 | C0751198 | |
| Disease | Hepatic Encephalopathy | 1.26e-03 | 13 | 121 | 2 | C0019151 | |
| Disease | Hepatic Coma | 1.26e-03 | 13 | 121 | 2 | C0019147 | |
| Disease | Small cell carcinoma of lung | 1.43e-03 | 54 | 121 | 3 | C0149925 | |
| Disease | vascular dementia (biomarker_via_orthology) | 1.47e-03 | 14 | 121 | 2 | DOID:8725 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of skin | 1.85e-03 | 59 | 121 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.85e-03 | 59 | 121 | 3 | C0037286 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.94e-03 | 128 | 121 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.94e-03 | 128 | 121 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.94e-03 | 128 | 121 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.94e-03 | 128 | 121 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.94e-03 | 128 | 121 | 4 | C0007134 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.94e-03 | 128 | 121 | 4 | DOID:4450 (is_marker_for) | |
| Disease | Cardiomyopathies | 2.05e-03 | 130 | 121 | 4 | C0878544 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 2.18e-03 | 17 | 121 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | susceptibility to vaginal yeast infection measurement | 2.44e-03 | 65 | 121 | 3 | EFO_0008412 | |
| Disease | protein Z-dependent protease inhibitor measurement | 2.44e-03 | 18 | 121 | 2 | EFO_0021849 | |
| Disease | cerebral microbleeds | 2.72e-03 | 19 | 121 | 2 | EFO_0010059 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.28e-03 | 148 | 121 | 4 | C0279702 | |
| Disease | in situ carcinoma (is_marker_for) | 3.33e-03 | 21 | 121 | 2 | DOID:8719 (is_marker_for) | |
| Disease | Primary familial hypertrophic cardiomyopathy | 3.65e-03 | 22 | 121 | 2 | cv:C0949658 | |
| Disease | Amphetamine-Related Disorders | 3.66e-03 | 75 | 121 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 3.66e-03 | 75 | 121 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 3.66e-03 | 75 | 121 | 3 | C0236804 | |
| Disease | Disproportionate short stature | 3.95e-03 | 77 | 121 | 3 | C0878659 | |
| Disease | spermatogenic failure (is_implicated_in) | 3.99e-03 | 23 | 121 | 2 | DOID:0111910 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IGYKERPQDVDQREA | 36 | P31749 | |
| LPLERRDNYTKAEEI | 476 | P06276 | |
| VINPIQQLRADLKYR | 126 | Q8NFR7 | |
| DCNYAIKRIRLPNRE | 616 | Q9NZJ5 | |
| TDEEYIINRAIRKPD | 111 | Q4VNC1 | |
| RKNLVPRDEELCIYE | 346 | Q8NFD2 | |
| RIYEQLPEVQKKREE | 4121 | Q8TCU4 | |
| QKEQARPEQEYKRTL | 266 | Q8TC94 | |
| LKYVIQRFAEDPRQE | 496 | Q8IY22 | |
| RETQARQEKPVLEYQ | 641 | Q5JTC6 | |
| LNEELLYRVVPRDQD | 116 | A6NHC0 | |
| DNYVRETKLDLQRVP | 11 | Q9NV06 | |
| LKRDYQDVRNEIPEE | 556 | P20020 | |
| PYEKTRNQRIQELID | 1186 | O95450 | |
| RQALRENVYPKLREF | 56 | Q9ULI1 | |
| ELQRRLKRLYPAVDE | 146 | Q96S59 | |
| DRPRRVEYFVDKQLQ | 341 | A6NED2 | |
| PLLEKRRQIINAIYE | 146 | Q9ULW6 | |
| GDRVKLERPVIYIDQ | 226 | P27338 | |
| YKEAEPLCQRALEIR | 311 | Q9NSK0 | |
| EDQRLLPCRKYEQIE | 376 | O75147 | |
| DHPENRIYRRKIEEL | 21 | Q96DC9 | |
| RIQEAVYKNVRPAEV | 221 | Q8TEM1 | |
| PEYQKRRLLQEILEN | 431 | Q9BR39 | |
| LDKRELNEVLQSRYP | 476 | Q9NU22 | |
| EYVLARIAAENLRKP | 11 | Q15842 | |
| AKEYLARREIPQLFE | 6 | Q9Y6K8 | |
| NRLYQKDLRAPDVVI | 71 | O95671 | |
| NAQKEDRVPVLEEYR | 876 | Q9NYF5 | |
| ERQDTKERYIPKQLN | 1281 | A9Z1Z3 | |
| YLIRDERKDPDPRVQ | 746 | Q8IY21 | |
| VQVPRRYDDKRNNIL | 171 | Q53TS8 | |
| QLRTLELPVDYREAK | 21 | A6NFU8 | |
| SKQVKEYRIQEPNRE | 1036 | Q96Q89 | |
| VDYLLEKNRVVRQNP | 241 | Q9HD67 | |
| PKIQIYREDCEARRQ | 1941 | Q8NG31 | |
| YREPRKGIQAEEVLQ | 446 | Q96PP8 | |
| YRIIDEEELNPENKR | 1001 | A8MYU2 | |
| RRYDDPEVQKDIKNV | 126 | P38646 | |
| YVHRDIKPDNILLDR | 191 | Q09013 | |
| QPVERVQRYQALLKE | 5831 | Q5VST9 | |
| ENQVRLEVKDPTRIY | 511 | O94856 | |
| AVKVLVRDDQRQYLP | 281 | P78367 | |
| DEVPSRAELIQYQKR | 486 | Q567U6 | |
| AYLRQLEEEQAVRPK | 176 | P14635 | |
| LEAKDPERTRQVYQA | 546 | Q9BZJ0 | |
| EKYNIRIPELVQRIE | 841 | Q8NFZ0 | |
| LNYVAARRQQELKDP | 186 | P26232 | |
| VELDEAQKPYLVQRR | 1011 | O14981 | |
| EVKINEARENYRPAA | 3641 | Q9UFH2 | |
| RKEQLERLYNRTPEQ | 226 | Q9NPF5 | |
| PTEAEVKLLRQYERE | 686 | Q8IVF7 | |
| VKLLRQYERERQPLE | 691 | Q8IVF7 | |
| PYKVLQLEQLARIRA | 146 | P0CW27 | |
| RVLRNNPKLREAYDA | 296 | P51841 | |
| VKRPLDREEQDIYFL | 2986 | Q8TDW7 | |
| VPRLLNRIYDKVQNE | 351 | Q9ULC5 | |
| PTENEVKVLRLYERE | 741 | Q96PY5 | |
| LRIRKEPLEFEQYLN | 206 | O75165 | |
| LRYNKIEENRIAPLA | 516 | O94769 | |
| RGVKKQDPQVERDLY | 131 | P59910 | |
| LERALYRIQEKRESP | 281 | Q14204 | |
| LIIVQRQDKLNPYRA | 181 | Q9BZJ6 | |
| LDREEKPVYILRAQA | 116 | P55285 | |
| ELRLRNYVPEDEDLK | 56 | Q8WUD4 | |
| RVAQYEREDPLKALA | 26 | Q3B820 | |
| EDLQRERIVYRDLKP | 301 | P32298 | |
| AKAEPRRIQELYLSE | 1116 | Q9C0D2 | |
| ESERKPDLRRDVYLQ | 71 | Q7Z6I6 | |
| VLRNPYREECLAKEQ | 161 | Q8N9Y4 | |
| LQPTEKQRYLDEAER | 111 | Q9P0W2 | |
| PQDLQARARVDEYLA | 86 | P30711 | |
| DDVRQYVVRKPLNKE | 151 | P62753 | |
| LFEQYREKRPEAAQL | 111 | P49589 | |
| VLQRLQEDKPDRVYF | 196 | Q969Y0 | |
| YDPREIRDIKQEESI | 121 | Q8IVG5 | |
| RNLRKQDYQEILDSP | 396 | Q8TBE7 | |
| DLEKHPYEQRVALLR | 136 | Q8WW32 | |
| VRIDNRLLEKPYVRD | 1311 | Q9Y520 | |
| SPDIYQQVRDELKRA | 361 | Q9UPW6 | |
| DAPADRQQYLRQEVL | 36 | O95721 | |
| PNARIEEFVYEKLDR | 71 | Q9Y371 | |
| QERIYQKDPVRAKAR | 701 | Q93073 | |
| YDRRALLPAVQQEQE | 466 | Q9NWF9 | |
| ERQKYFELEVRVPQA | 1356 | Q14160 | |
| KEAYLAPVRREQEAA | 101 | A8MXQ7 | |
| VREELKPDQKQRDYI | 351 | Q9UHB9 | |
| NYLKPRAEEERRIAA | 31 | P56385 | |
| DQVIYPDGREDQKRK | 521 | P28288 | |
| PKILCQEEQDAYRRI | 236 | P46736 | |
| ELRRELPAKQAEYCI | 856 | Q08043 | |
| YLVNKPSEERVREII | 241 | Q7LG56 | |
| YNPRQRKLRNLIIED | 606 | P10074 | |
| EVYLDKLRRECPLAQ | 71 | Q9UID3 | |
| EERRKNYPTLANIER | 241 | Q9UHK0 | |
| DAYKIRIRIDDEPAN | 56 | Q92963 | |
| EVRAQLLELPYARKE | 211 | P50453 | |
| EAKAPILKRQREEYE | 431 | P12270 | |
| DSEVLEERQKRLPYV | 31 | Q9NPL8 | |
| VQEPDLAQVLKRYRD | 956 | O15067 | |
| RFYELVNPLRKEICE | 186 | Q8WXW3 | |
| LISKIREEYPDRIIN | 151 | A6NNZ2 | |
| PYRQDLLAKCDRVDQ | 536 | P18206 | |
| EESVIKIDLFRNRYP | 591 | Q5GH76 | |
| YLRKPEKERIEAQNR | 16 | Q9UKX3 | |
| RIREDIAKYLRNLDP | 266 | O95391 | |
| KENVDYIIQELRRPK | 76 | Q9NRW7 | |
| QKRYVLEEAEQLEPR | 166 | Q8NAV1 | |
| RIREDYPQKEILRAL | 16 | Q9ULI2 | |
| RPIRLEEILEYNEKT | 351 | Q86WI1 | |
| VRIAYLRKNFDQEPL | 146 | Q8IZJ1 | |
| PQLLVSEDRKAVRYE | 306 | Q495X7 | |
| LIDLKRRYNFPVEVE | 1981 | P78527 | |
| LDKYQENPERHLRQV | 136 | P21506 | |
| VAREKLAREEPDIYQ | 656 | Q07157 | |
| DRDRKRAQLILQYIP | 631 | Q7Z3V4 | |
| RQQQYKFLPTELRED | 2526 | Q9Y4G6 | |
| QIPAQRDLYRDFRKE | 246 | Q63HK3 | |
| RPEARKRLLSYINEE | 651 | Q6ZXV5 | |
| KEITIRDQEAPYLLR | 651 | P17948 | |
| EIYPEKRFAQPRQED | 1146 | O15016 | |
| YRKILEEEQLRPERE | 1746 | Q07283 | |
| DKYPAARLRQELQRV | 506 | Q5TAA0 | |
| ERKRQERLEQYCGEP | 186 | Q49AM3 | |
| YENDPELEKIRRERN | 46 | Q9BV57 | |
| PDQYTEALAQRDKRI | 161 | Q5VU43 |